Unknown

Dataset Information

C6 Hydroxymethyl-Substituted Carbapenem MA-1-206 Inhibits the Major <i>Acinetobacter baumannii</i> Carbapenemase OXA-23 by Impeding Deacylation.


ABSTRACT: Acinetobacter baumannii has become a major nosocomial pathogen, as it is often multidrug-resistant, which results in infections characterized by high mortality rates. The bacterium achieves high levels of resistance to β-lactam antibiotics by producing β-lactamases, enzymes which destroy these valuable agents. Historically, the carbapenem family of β-lactam antibiotics have been the drugs of choice for treating A. baumannii infections. However, their effectiveness has been significantly diminished due to the pathogen's production of carbapenem-hydrolyzing class D β-lactamases (CHDLs); thus, new antibiotics and inhibitors of these enzymes are urgently needed. Here, we describe a new carbapenem antibiotic, MA-1-206, in which the canonical C6 hydroxyethyl group has been replaced with hydroxym

SUBMITTER: Stewart NK 

PROVIDER: S-EPMC9239083 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature